172 related articles for article (PubMed ID: 38336101)
1. Sterile inflammation induces vasculopathy and chronic lung injury in murine sickle cell disease.
Rarick KR; Li K; Teng RJ; Jing X; Martin DP; Xu H; Jones DW; Hogg N; Hillery CA; Garcia G; Day BW; Naylor S; Pritchard KA
Free Radic Biol Med; 2024 Mar; 215():112-126. PubMed ID: 38336101
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease mice.
Zhang H; Xu H; Weihrauch D; Jones DW; Jing X; Shi Y; Gourlay D; Oldham KT; Hillery CA; Pritchard KA
J Lipid Res; 2013 Nov; 54(11):3009-15. PubMed ID: 23956444
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation.
Blonder JP; Mutka SC; Sun X; Qiu J; Green LH; Mehra NK; Boyanapalli R; Suniga M; Look K; Delany C; Richards JP; Looker D; Scoggin C; Rosenthal GJ
BMC Pulm Med; 2014 Jan; 14():3. PubMed ID: 24405692
[TBL] [Abstract][Full Text] [Related]
4. S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis.
Saxena N; Won J; Choi S; Singh AK; Singh I
Free Radic Biol Med; 2018 Jun; 121():57-68. PubMed ID: 29694854
[TBL] [Abstract][Full Text] [Related]
5. Discovery of s-nitrosoglutathione reductase inhibitors: potential agents for the treatment of asthma and other inflammatory diseases.
Sun X; Wasley JW; Qiu J; Blonder JP; Stout AM; Green LS; Strong SA; Colagiovanni DB; Richards JP; Mutka SC; Chun L; Rosenthal GJ
ACS Med Chem Lett; 2011 May; 2(5):402-6. PubMed ID: 24900320
[TBL] [Abstract][Full Text] [Related]
6. Soluble MD-2 and Heme in Sickle Cell Disease Plasma Promote Pro-Inflammatory Signaling in Endothelial Cells.
Zhang P; Nguyen J; Abdulla F; Nelson AT; Beckman JD; Vercellotti GM; Belcher JD
Front Immunol; 2021; 12():632709. PubMed ID: 33841413
[TBL] [Abstract][Full Text] [Related]
7. Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammation.
Xu H; Wandersee NJ; Guo Y; Jones DW; Holzhauer SL; Hanson MS; Machogu E; Brousseau DC; Hogg N; Densmore JC; Kaul S; Hillery CA; Pritchard KA
Blood; 2014 Dec; 124(26):3978-81. PubMed ID: 25339362
[TBL] [Abstract][Full Text] [Related]
8. Targeting GSNOR for functional recovery in a middle-aged mouse model of stroke.
Khan M; Kumar P; Qiao F; Islam SMT; Singh AK; Won JS; Feng W; Singh I
Brain Res; 2020 Aug; 1741():146879. PubMed ID: 32418890
[TBL] [Abstract][Full Text] [Related]
9. N-acetyl-lysyltyrosylcysteine amide, a novel systems pharmacology agent, reduces bronchopulmonary dysplasia in hyperoxic neonatal rat pups.
Teng RJ; Jing X; Martin DP; Hogg N; Haefke A; Konduri GG; Day BW; Naylor S; Pritchard KA
Free Radic Biol Med; 2021 Apr; 166():73-89. PubMed ID: 33607217
[TBL] [Abstract][Full Text] [Related]
10. O-Aminobenzoyl-S-nitrosoglutathione: A fluorogenic, cell permeable, pseudo-substrate for S-nitrosoglutathione reductase.
Sun BL; Palmer L; Alam SR; Adekoya I; Brown-Steinke K; Periasamy A; Mutus B
Free Radic Biol Med; 2017 Jul; 108():445-451. PubMed ID: 28419866
[TBL] [Abstract][Full Text] [Related]
11. Critical role of C5a in sickle cell disease.
Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase.
Green LS; Chun LE; Patton AK; Sun X; Rosenthal GJ; Richards JP
Biochemistry; 2012 Mar; 51(10):2157-68. PubMed ID: 22335564
[TBL] [Abstract][Full Text] [Related]
13. The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinase.
Vogel S; Arora T; Wang X; Mendelsohn L; Nichols J; Allen D; Shet AS; Combs CA; Quezado ZMN; Thein SL
Blood Adv; 2018 Oct; 2(20):2672-2680. PubMed ID: 30333099
[TBL] [Abstract][Full Text] [Related]
14. Kinetic and cellular characterization of novel inhibitors of S-nitrosoglutathione reductase.
Sanghani PC; Davis WI; Fears SL; Green SL; Zhai L; Tang Y; Martin E; Bryan NS; Sanghani SP
J Biol Chem; 2009 Sep; 284(36):24354-62. PubMed ID: 19596685
[TBL] [Abstract][Full Text] [Related]
15. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia.
Belcher JD; Gomperts E; Nguyen J; Chen C; Abdulla F; Kiser ZM; Gallo D; Levy H; Otterbein LE; Vercellotti GM
PLoS One; 2018; 13(10):e0205194. PubMed ID: 30308028
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 5-(2-chloro-4'-(1H-imidazol-1-yl)-[1,1'-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPD.
Muthukaman N; Deshmukh S; Tondlekar S; Tambe M; Pisal D; Sarode N; Mhatre S; Chakraborti S; Shah D; Bhosale VM; Kulkarni A; Mahat MYA; Jadhav SB; Gudi GS; Khairatkar-Joshi N; Gharat LA
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3766-3773. PubMed ID: 30340896
[TBL] [Abstract][Full Text] [Related]
17. Discovery of potent and novel S-nitrosoglutathione reductase inhibitors devoid of cytochrome P450 activities.
Sun X; Qiu J; Strong SA; Green LS; Wasley JW; Blonder JP; Colagiovanni DB; Mutka SC; Stout AM; Richards JP; Rosenthal GJ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5849-53. PubMed ID: 21855338
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.
Sun X; Qiu J; Strong SA; Green LS; Wasley JW; Blonder JP; Colagiovanni DB; Stout AM; Mutka SC; Richards JP; Rosenthal GJ
Bioorg Med Chem Lett; 2012 Mar; 22(6):2338-42. PubMed ID: 22342142
[TBL] [Abstract][Full Text] [Related]
19. L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease.
Ou J; Ou Z; Jones DW; Holzhauer S; Hatoum OA; Ackerman AW; Weihrauch DW; Gutterman DD; Guice K; Oldham KT; Hillery CA; Pritchard KA
Circulation; 2003 May; 107(18):2337-41. PubMed ID: 12732610
[TBL] [Abstract][Full Text] [Related]
20. Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.
Novelli EM; Little-Ihrig L; Knupp HE; Rogers NM; Yao M; Baust JJ; Meijles D; St Croix CM; Ross MA; Pagano PJ; DeVallance ER; Miles G; Potoka KP; Isenberg JS; Gladwin MT
Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1150-L1164. PubMed ID: 30892078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
